Edesa Biotech Inc buy Brookline Capital Management
Start price
12.10.23
/
50%
€0.39
Target price
12.10.24
€54.12
Performance (%)
0.00%
End price
13.10.24
-
Summary
This prediction is currently being closed. Brookline_Capital_Ma's BUY prediction for Edesa Biotech Inc is currently unchanged. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Edesa Biotech Inc | - | - | - |
| iShares Core DAX® | 0.300% | 4.701% | 4.537% |
| iShares Nasdaq 100 | 0.434% | 12.255% | 31.983% |
| iShares Nikkei 225® | 1.633% | 12.616% | 43.258% |
| iShares S&P 500 | 0.566% | 7.786% | 23.475% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Edesa Biotech Inc diskutieren
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at Brookline Capital Management. They now have a $57.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat
In the thread Trading Edesa Biotech Inc
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten